Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
ARA-290 (Cibinetide)
History
ARA-290 is a synthetic 11-amino acid peptide derived from erythropoietin (EPO). It was developed to provide the tissue-protective and anti-inflammatory benefits of EPO without stimulating red blood cell production.
Research Use
Researchers study ARA-290 for its potential role in reducing inflammation, promoting nerve repair, and protecting tissues after injury. It has been investigated in neuropathic pain, small fiber neuropathy, diabetic complications, and inflammatory conditions.
Clinical Highlights
Studied for reducing neuropathic pain symptoms
May support nerve regeneration and tissue repair
Investigated for diabetic and small fiber neuropathy
Designed to activate the body’s innate repair mechanisms without increasing red blood cell production
ARA-290 (Cibinetide)
History
ARA-290 is a synthetic 11-amino acid peptide derived from erythropoietin (EPO). It was developed to provide the tissue-protective and anti-inflammatory benefits of EPO without stimulating red blood cell production.
Research Use
Researchers study ARA-290 for its potential role in reducing inflammation, promoting nerve repair, and protecting tissues after injury. It has been investigated in neuropathic pain, small fiber neuropathy, diabetic complications, and inflammatory conditions.
Clinical Highlights
Studied for reducing neuropathic pain symptoms
May support nerve regeneration and tissue repair
Investigated for diabetic and small fiber neuropathy
Designed to activate the body’s innate repair mechanisms without increasing red blood cell production